Last Week’s Top-3 Most Read Posts On Pulmonary Hypertension

Written by Marta Ribeiro |

ph-top3

Read the articles:

1.  Eiger BioPharmaceuticals’ PAH Drug Granted Orphan Drug Status by FDA

2. PAH Management via Oral Therapy Shows Advantages and Drawbacks

3. Therapy Options Exist for PAH Patients Unresponsive to Medications

 

Marta Ribeiro avatar

About the Author

Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

Pulmonary hypertension (PHT) top 3


Recommended reading